Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity
- 1 August 2000
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 10 (15) , 1687-1690
- https://doi.org/10.1016/s0960-894x(00)00323-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The design, synthesis, and biological evaluation of analogues of the serine-threonine protein phosphatase 1 and 2A selective inhibitor microcystin LA: rational modifications imparting PP1 selectivityBioorganic & Medicinal Chemistry, 1999
- Regulation of Neuronal PP1 and PP2A During DevelopmentPublished by Springer Nature ,1998
- Inhibition of protein phosphatase 2A by cantharidin analoguesBioorganic & Medicinal Chemistry Letters, 1996
- Cantharidin-binding protein: identification as protein phosphatase 2A.Proceedings of the National Academy of Sciences, 1992
- Creative blocks: cell-cycle checkpoints and feedback controlsNature, 1992
- Office Therapy for Human Papillomavirus Infection in Nongenital SitesDermatologic Clinics, 1991
- Medical uses of mylabris in ancient China and recent studiesJournal of Ethnopharmacology, 1989
- Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.Journal of Biological Chemistry, 1984
- Synthesis and some reductions of endo- and exo-3,6-epoxy-Δ4-tetrahydrophthalic anhydrideTetrahedron, 1973